Table 2 Comparison of the clinical parameters in the psoriatic arthritic patients (n = 50) with and without fibromyalgia
Characteristics | Patients with FM (n = 17) | Patients without FM (n = 33) | p |
|---|---|---|---|
n (%) | n (%) | ||
Gender | |||
female | 17 (34%) | 19 (38%) | 0.002* |
male | 0 (0%) | 14 (28%) | |
Median (min-max) | Median (min-max) | ||
Age (years) | 48 (25–66) | 47 (23–64) | 0.264 |
Psoriasis duration (years) | 17 (5–50) | 15 (1–38) | 0.324 |
Arthritis duration (years) | 10 (1–30) | 5 (1–25) | 0.271 |
ESR (mm/h) | 20 (4–97) | 12 (2–57) | 0.263 |
CRP (mg/l) | 3 (0.2–18.2) | 0.56 (0.1–14.6) | 0.050 |
DAS 28 | 3.5 (2.1–5.2) | 2.8 (1.2–5.1) | 0.012* |
VAS pain score (0–10) | 6 (3–7) | 3 (0–9) | 0.002* |
LEI score (0–6) | 0 (0–3) | – | 0.004* |
MAF score (0–50) | 33.4 (3.1–43.2) | 12.9 (1–43.5) | 0.000** |